Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Chubb
US Army
Cipla
McKinsey
McKesson
Cantor Fitzgerald
Teva
AstraZeneca
Chinese Patent Office

Generated: January 21, 2018

DrugPatentWatch Database Preview

TECHNETIUM TC 99M SESTAMIBI Drug Profile

« Back to Dashboard

Which patents cover Technetium Tc 99m Sestamibi, and what generic alternatives are available?

Technetium Tc 99m Sestamibi is a drug marketed by Cardinal Health 414, Jubilant Draximage, and Pharmalucence. and is included in three NDAs.

The generic ingredient in TECHNETIUM TC 99M SESTAMIBI is technetium tc-99m sestamibi kit. There are four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the technetium tc-99m sestamibi kit profile page.
Summary for TECHNETIUM TC 99M SESTAMIBI
Drug patent expirations by year for TECHNETIUM TC 99M SESTAMIBI
Pharmacology for TECHNETIUM TC 99M SESTAMIBI

US Patents and Regulatory Information for TECHNETIUM TC 99M SESTAMIBI

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cardinal Health 414 TECHNETIUM TC 99M SESTAMIBI technetium tc-99m sestamibi kit INJECTABLE;INJECTION 078809-001 Apr 28, 2009 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Jubilant Draximage TECHNETIUM TC 99M SESTAMIBI technetium tc-99m sestamibi kit INJECTABLE;INJECTION 078806-001 Apr 29, 2009 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmalucence TECHNETIUM TC 99M SESTAMIBI technetium tc-99m sestamibi kit INJECTABLE;INJECTION 079157-001 Jul 10, 2009 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Harvard Business School
Fuji
Novartis
US Department of Justice
Mallinckrodt
McKesson
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot